California-based Sienna Biopharmaceuticals Inc. appointed John Smither as CFO.
Smither served as the company's CFO from January 2016 to March 2017, and subsequently served as an independent consultant in the biopharmaceutical industry.
Smither will succeed Richard Peterson, who resigned for personal reasons, effective March 29.